Private Hospital Sealed After Woman, Child Die During Delivery In Fazilka

Fazilka : Dr Karamjeet Singh, practising at a private hospital in Arniwala sub-tehsil of Fazilka district, has been booked under Section 304 (causing death by negligence) of the IPC today as a pregnant woman and her child died during a delivery procedure on June 5.

The relatives of the deceased and a large number of villagers had been staging a protest by blocking the Fazilka-Malout road since Tuesday, demanding the registration of a murder case under Section 302 of the IPC against the doctor.

They were also seeking the registration of an FIR against Medical Officer (surgeon) Dr Kirti, posted at the Community Health Centre (CHC) in Dabwala Kalan village, who had referred the patient to the private hospital.

The protesters had kept the body of the deceased woman at the protest site. They lifted the dharna after Dr Babita, officiating Civil Surgeon, said Dr Kriti had been placed under suspension.

Meharban Singh said he had taken his pregnant wife Veerpal Kaur to the CHC on June 5 and a surgeon informed them that a delivery could not be performed there. The surgeon referred them to the private hospital and she, accompanied by Nachhatar Singh, took them there.

Dr Babita said the operation theatre and the hospital of Dr Karamjeet had been sealed. She said disciplinary action had been recommended against the surgeon and a three-member enquiry committee had been constituted.

Notably, the name of Dr Kirti figures in the FIR but no section of the IPC has been imposed on her on plea that criminal action shall be taken after the outcome of the enquiry being conducted by the Health Department.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India